Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Opinions Regarding Benzodiazepine Teaching and Prescribing Among Trainees in Psychiatry.

Garakani A, Abdullah HM, Chang CM, Mendelsohn N, Lapidus KAB.

Acad Psychiatry. 2017 Jul 6. doi: 10.1007/s40596-017-0750-0. [Epub ahead of print]

PMID:
28685349
2.

Challenges in Testing Intranasal Ketamine in Obsessive-Compulsive Disorder.

Rodriguez CI, Lapidus KAB, Zwerling J, Levinson A, Mahnke A, Steinman SA, Kalanthroff E, Simpson HB.

J Clin Psychiatry. 2017 Apr;78(4):466-467. doi: 10.4088/JCP.16cr11234. No abstract available.

3.

The Significance of the Default Mode Network (DMN) in Neurological and Neuropsychiatric Disorders: A Review.

Mohan A, Roberto AJ, Mohan A, Lorenzo A, Jones K, Carney MJ, Liogier-Weyback L, Hwang S, Lapidus KA.

Yale J Biol Med. 2016 Mar 24;89(1):49-57. eCollection 2016 Mar. Review.

4.

First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone.

Roberto AJ, Lorenzo A, Li KJ, Young J, Mohan A, Pinnaka S, Lapidus KA.

Case Rep Psychiatry. 2016;2016:7257489. doi: 10.1155/2016/7257489. Epub 2016 Jun 26.

5.

The impact of simulated patient death on medical students' stress response and learning of ACLS.

DeMaria S, Silverman ER, Lapidus KA, Williams CH, Spivack J, Levine A, Goldberg A.

Med Teach. 2016 Jul;38(7):730-7. doi: 10.3109/0142159X.2016.1150986. Epub 2016 Apr 7.

PMID:
27052665
6.

Resting-state functional connectivity of the human habenula in healthy individuals: Associations with subclinical depression.

Ely BA, Xu J, Goodman WK, Lapidus KA, Gabbay V, Stern ER.

Hum Brain Mapp. 2016 Jul;37(7):2369-84. doi: 10.1002/hbm.23179. Epub 2016 Mar 16.

7.

Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy.

Dubin MJ, Mao X, Banerjee S, Goodman Z, Lapidus KA, Kang G, Liston C, Shungu DC.

J Psychiatry Neurosci. 2016 Apr;41(3):E37-45.

8.

Somnambulism During Monotherapy With Mixed Amphetamine Salts.

Pinnaka S, Gosai K, Czekierdowski C, Siller PP, Lapidus KA.

J Clin Psychopharmacol. 2016 Apr;36(2):187-9. doi: 10.1097/JCP.0000000000000475. No abstract available.

9.

Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis.

Xu Y, Hackett M, Carter G, Loo C, Gálvez V, Glozier N, Glue P, Lapidus K, McGirr A, Somogyi AA, Mitchell PB, Rodgers A.

Int J Neuropsychopharmacol. 2016 Apr 20;19(4). pii: pyv124. doi: 10.1093/ijnp/pyv124. Print 2016 Apr. Review.

10.

Aripiprazole-Induced Transient Morning Pseudoneutropenia in an 11-Year-Old Male.

Pinnaka S, Roberto AJ, Giordano A, Siller P, Lapidus K.

J Child Adolesc Psychopharmacol. 2016 Nov;26(9):858-859. Epub 2015 Sep 23. No abstract available.

PMID:
26397725
11.

Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress.

Hodes GE, Pfau ML, Leboeuf M, Golden SA, Christoffel DJ, Bregman D, Rebusi N, Heshmati M, Aleyasin H, Warren BL, Lebonté B, Horn S, Lapidus KA, Stelzhammer V, Wong EH, Bahn S, Krishnan V, Bolaños-Guzman CA, Murrough JW, Merad M, Russo SJ.

Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16136-41. doi: 10.1073/pnas.1415191111. Epub 2014 Oct 20.

12.

Adolescent catatonia successfully treated with Lorazepam and aripiprazole.

Roberto AJ, Pinnaka S, Mohan A, Yoon H, Lapidus KA.

Case Rep Psychiatry. 2014;2014:309517. doi: 10.1155/2014/309517. Epub 2014 Aug 12.

13.

Obsessive-compulsive disorder.

Goodman WK, Grice DE, Lapidus KA, Coffey BJ.

Psychiatr Clin North Am. 2014 Sep;37(3):257-67. doi: 10.1016/j.psc.2014.06.004. Epub 2014 Jul 23. Review.

PMID:
25150561
14.

Dosing and effectiveness of ketamine anesthesia for electroconvulsive therapy (ECT): a case series.

Bryson EO, Ahle GM, Liebman LS, Aloysi AS, Majeske MF, Lapidus KA, Kellner CH.

Australas Psychiatry. 2014 Oct;22(5):467-9. doi: 10.1177/1039856214545547. Epub 2014 Aug 17.

PMID:
25135435
15.

Neuromodulation for obsessive-compulsive disorder.

Lapidus KA, Stern ER, Berlin HA, Goodman WK.

Neurotherapeutics. 2014 Jul;11(3):485-95. doi: 10.1007/s13311-014-0287-9. Review.

16.

A randomized controlled trial of intranasal ketamine in major depressive disorder.

Lapidus KA, Levitch CF, Perez AM, Brallier JW, Parides MK, Soleimani L, Feder A, Iosifescu DV, Charney DS, Murrough JW.

Biol Psychiatry. 2014 Dec 15;76(12):970-6. doi: 10.1016/j.biopsych.2014.03.026. Epub 2014 Apr 3.

17.

Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.

Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwood K, Aan Het Rot M, Lapidus KA, Wan LB, Iosifescu D, Charney DS.

JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62.

PMID:
24740528
18.

In vivo (1)H MRS study of potential associations between glutathione, oxidative stress and anhedonia in major depressive disorder.

Lapidus KA, Gabbay V, Mao X, Johnson A, Murrough JW, Mathew SJ, Shungu DC.

Neurosci Lett. 2014 May 21;569:74-9. doi: 10.1016/j.neulet.2014.03.056. Epub 2014 Apr 2.

19.

Increased metabolic activity in the septum and habenula during stress is linked to subsequent expression of learned helplessness behavior.

Mirrione MM, Schulz D, Lapidus KA, Zhang S, Goodman W, Henn FA.

Front Hum Neurosci. 2014 Feb 3;8:29. doi: 10.3389/fnhum.2014.00029. eCollection 2014.

20.

Novel glutamatergic drugs for the treatment of mood disorders.

Lapidus KA, Soleimani L, Murrough JW.

Neuropsychiatr Dis Treat. 2013;9:1101-12. doi: 10.2147/NDT.S36689. Epub 2013 Aug 7.

Supplemental Content

Loading ...
Support Center